According to a new report, published by KBV research, The Global Cytosine Market size is expected to reach $612.4 million by 2030, rising at a market growth of 9.2% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,124.51 Tonnes experiencing a growth of 8.4% (2019-2022).
The Pharmaceutical segment is growing at a CAGR of 8.5 % during the forecast period. Due to extensive usage of cytosine bases in genetic testing and analysis. Its role in DNA sequencing and genomics enables the identification of specific genetic variations and mutations that can influence an individual's response to certain medications. It is involved in drug discovery & development. Pharmaceutical companies use it and other nucleotide bases in target identification, lead optimization, and preclinical studies.
Full Report: https://www.kbvresearch.com/cytosine-market/
The North America region dominated the Global Cytosine Market, By Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $236.3 million by 2030. The Europe region is anticipated to grow CAGR of 8.8% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 9.9% during (2023 - 2030).
By End-use (Volume, Tonnes, USD Million, 2019-2030)
Unique Offerings 
